RETRACTED: Oroxylin A inhibits carcinogen-induced skin tumorigenesis through inhibition of inflammation by regulating SHCBP1 in mice
- 9 January 2020
- journal article
- retracted article
- Published by Elsevier in International Immunopharmacology
- Vol. 80, 106123
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Oroxylin A attenuates cigarette smoke-induced lung inflammation by activating Nrf2International Immunopharmacology, 2016
- Oroxylin a could be a Promising Radiosensitizer for Esophageal Squamous Cell Carcinoma by Inducing G2/M Arrest and Activating ApoptosisPathology and Oncology Research, 2016
- SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell lineGene, 2016
- Oroxylin A Inhibits Allergic Airway Inflammation in Ovalbumin (OVA)-Induced Asthma Murine ModelInflammation, 2016
- Chemopreventive efficacy of menthol on carcinogen-induced cutaneous carcinoma through inhibition of inflammation and oxidative stress in miceFood and Chemical Toxicology, 2015
- Cancer-promoting effect of capsaicin on DMBA/TPA-induced skin tumorigenesis by modulating inflammation, Erk and p38 in miceFood and Chemical Toxicology, 2015
- SHCBP1 is required for midbody organization and cytokinesis completionCell Cycle, 2014
- Unexpected Phenotype of Mice Lacking Shcbp1, a Protein Induced during T Cell ProliferationPLOS ONE, 2014
- Targeting SHCBP1 Inhibits Cell Proliferation in Human Hepatocellular Carcinoma CellsAsian Pacific Journal of Cancer Prevention, 2013
- Measles Virus Nonstructural C Protein Modulates Viral RNA Polymerase Activity by Interacting with Host Protein SHCBP1Journal of Virology, 2013